Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB4A | P04350 | 4/20 | 0.68 |
| ▸ | TUBB | P07437 | 4/20 | 0.68 |
| ▸ | TUBA3C | P0DPH7 | 4/20 | 0.68 |
| ▸ | TUBA1B | P68363 | 4/20 | 0.68 |
| ▸ | TUBA4A | P68366 | 4/20 | 0.68 |
| ▸ | TUBB4B | P68371 | 4/20 | 0.68 |
| ▸ | TUBB3 | Q13509 | 4/20 | 0.68 |
| ▸ | TUBB2A | Q13885 | 4/20 | 0.68 |
| ▸ | TUBB8 | Q3ZCM7 | 4/20 | 0.68 |
| ▸ | TUBA3E | Q6PEY2 | 4/20 | 0.68 |
| ▸ | TUBA1A | Q71U36 | 4/20 | 0.68 |
| ▸ | TUBA1C | Q9BQE3 | 4/20 | 0.68 |
| ▸ | TUBB6 | Q9BUF5 | 4/20 | 0.68 |
| ▸ | TUBB2B | Q9BVA1 | 4/20 | 0.68 |
| ▸ | TUBB1 | Q9H4B7 | 4/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.64 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tritoqualine SCHEMBL1627004 | 1.00 | TUBB4A (0.68) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Tritoqualine SCHEMBL29606368 | 1.00 | TUBB4A (0.68) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Tritoqualine SCHEMBL10076978 | 1.00 | TUBB4A (0.68) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Tritoqualine SCHEMBL14135610 | 1.00 | TUBB4A (0.68) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Tritoqualine SCHEMBL16876635 | 0.99 | TUBB4A (0.67) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL2631317 | 0.98 | TUBB4A (0.68) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Tritoqualine SCHEMBL18037822 | 0.97 | TUBB4A (0.64) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Tritoqualine SCHEMBL18037824 | 0.96 | TUBB4A (0.64) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Tritoqualine SCHEMBL18037823 | 0.96 | TUBB4A (0.64) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| Tritoqualine SCHEMBL18037828 | 0.95 | TUBB4A (0.63) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704971-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024229174-A1 | GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY | Cognito Therapeutics, Inc. (US) | 2024-11-07 | — | — | WO | claimed |
| EP-4138833-B1 | USE OF TRITOQUALINE FOR TREATING DRY EYES, MEIBOMIAN GLAND DYSFUNCTIONS AND LACRIMAL GLAND DYSFUNCTIONS | H4 ORPHAN PHARMA (FR) | 2024-06-05 | — | — | EP | claimed |
| US-20230201190-A1 | USE OF MULTIFUNCTIONAL LIGANDS FOR TREATING THE RESPIRATORY DISTRESS AND CYTOKINE STORM SYNDROMES ASSOCIATED WITH CORONAVIRUS VIRAL INFECTIONS | TERRASSE, Gaëtan (FR) | 2023-06-29 | — | — | US | claimed |
| CN-116322689-A | Use of multifunctional ligands for the treatment of respiratory distress and cytokine storm syndrome associated with coronavirus viral infection | H4奥芬制药 | 2023-06-23 | — | — | CN | claimed |
| US-20230181562-A1 | USE OF A MULTIFUNCTIONAL LIGAND FOR TREATING DRY EYES, MEIBOMIAN GLAND DYSFUNCTIONS AND LACRIMAL GLAND DYSFUNCTIONS | TERRASSE, Gaëtan (FR) | 2023-06-15 | — | — | US | claimed |
| EP-4138833-A1 | USE OF A MULTIFUNCTIONAL LIGAND FOR TREATING DRY EYES, MEIBOMIAN GLAND DYSFUNCTIONS AND LACRIMAL GLAND DYSFUNCTIONS | H4 Orphan Pharma (FR) | 2023-03-01 | — | — | EP | claimed |
| EP-2854947-B1 | USE OF AN H4 AGONIST MOLECULE FOR TREATING CYSTIC FIBROSIS | TERRASSE GAETAN (FR) | 2021-12-29 | — | — | EP | claimed |
| WO-2021213891-A1 | USE OF A MULTIFUNCTIONAL LIGAND FOR TREATING DRY EYES, MEIBOMIAN GLAND DYSFUNCTIONS AND LACRIMAL GLAND DYSFUNCTIONS | H4 ORPHAN PHARMA (FR) | 2021-10-28 | — | — | WO | claimed |
| EP-2459227-B1 | Prodrugs containing an aromatic amine connected by an amide bond to a carrier | ASCENDIS PHARMA AS (DK) | 2021-03-17 | — | — | EP | claimed |
| US-6632217-B2 | Implantable osmotic pump | MICROSOLUTIONS, INC. | 2003-10-14 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| US-20030135202-A1 | Implantable osmotic pump | MICROSOLUTIONS, INC. | 2003-07-17 | — | — | US | claimed |
| US-20030104013-A1 | Anti-allergic pharmaceutical composition containing at least one allergen and at least one antihistamine compound | ANTIALIS (FR) | 2003-06-05 | — | — | US | claimed |
| US-20020183722-A1 | Implantable osmotic pump | MICROSOLUTIONS, INC., | 2002-12-05 | — | — | US | claimed |
| WO-2002085428-A2 | IMPLANTABLE OSMOTIC PUMP | MICROSOLUTIONS, INC. (US) | 2002-10-31 | — | — | WO | claimed |
| WO-2002078736-A2 | ANTIALLERGIC PHARMACEUTICAL COMPOSITION | ANTIALIS (FR) | 2002-10-10 | — | — | WO | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0201359-A2 | Use of phthalide isoquinoline derivatives for treatments inhibiting the formation of lipid peroxides | MITSUBISHI KASEI CORPORATION (JP) | 1986-11-12 | — | — | EP | claimed |